OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Search Results

Your search returned 10 results.
Search:

SKU Category Vector Description Price Delivery
SC119289 Human cDNA pCMV6-XL4 CNGA3 (untagged)-ORIGENE UNIQUE VARIANT 1 of Human cyclic nucleotide gated channel alpha 3 (CNGA3), NM_001298.1 $680 Immediate
SC310166 Human cDNA pCMV6-Entry CNGA3 (untagged)-Human cyclic nucleotide gated channel alpha 3 (CNGA3), transcript variant 1 NM_001298.1 $680 2-3 weeks
RC221063 Human ORF PS100001 CNGA3 (Myc-DDK-tagged)-Human cyclic nucleotide gated channel alpha 3 (CNGA3), transcript variant 1 $540 Immediate
RC221063L1 Human ORF PS100064 Lenti ORF clone of Human cyclic nucleotide gated channel alpha 3 (CNGA3), transcript variant 1 , Myc-DDK-tagged $910 3-4 weeks
RC221063L2 Human ORF PS100071 Lenti ORF clone of Human cyclic nucleotide gated channel alpha 3 (CNGA3), transcript variant 1, mGFP tagged $1000 3-4 weeks
RG221063 Human ORF PS100010 CNGA3 (GFP-tagged) - Human cyclic nucleotide gated channel alpha 3 (CNGA3), transcript variant 1 $590 2-3 weeks
HP233335 Human Primer qSTAR qPCR primer pairs against Homo sapiens gene CNGA3 NM_001298 $95 3 - 5 Days
LY420024 Lysate LC420024 Transient overexpression lysate of cyclic nucleotide gated channel alpha 3 (CNGA3), transcript variant 1 $480 5 days
LY429061 Lysate LC429061 Transient overexpression lysate of cyclic nucleotide gated channel alpha 3 (CNGA3), transcript variant 1 $480 5 days
/ UTR pMirTarget 3`UTR clone of cyclic nucleotide gated channel alpha 3 (CNGA3) transcript variant 1 for miRNA target validation NM_001298.2 $495 3-4 weeks
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title